Champignon Brands Acquires Ketamine Clinic Operator AltMed Capital

Psychedelics research company Champignon Brands SHRM SHRMF announced Friday it is acquiring AltMed Capital Corp.

Run by Dr. Roger McIntyre, AltMed has been operating a ketamine clinic, the Health Canada-approved Canadian Rapid Treatment Centre of Excellence (CRTCE), for more than 18 months now.

Dr. McIntyre is well known in his field, having published more than 600 articles. AltMed’s director, Pat McCutcheon, is the co-founder and CEO of MediPharm Labs LABS MEDIF.

Chatting with Benzinga, Dr. McIntyre said, "Our new corporation is the largest and most influential company in the world that integrates both research and development of ketamine and psychedelic medicines along with excellence in the multidisciplinary care of persons with mood and related disorders (e.g. PTSD, pain substance abuse)."